Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
Ebiomedicine|September 4, 2018
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialMabel Toribio, Kathleen V Fitch, Lauren Stone, et al.AIDS (London, England)|October 4, 2012
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllersFlorencia Pereyra, Janet Lo, Virginia A Triant, et al.AIDS (London, England)|June 18, 2016
Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individualsKathleen V Fitch, Christopher DeFilippi, Robert Christenson, et al.Nutrition & Diabetes|February 27, 2019
Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIVLindsay T Fourman, Emma M Kileel, Jane Hubbard, et al.The Journal of Infectious Diseases|July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARETriin Umbleja, Todd T Brown, Edgar T Overton, et al.The Lancet. HIV|October 2, 2015
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trialJanet Lo, Michael T Lu, Ezinne J Ihenachor, et al.Metabolism: Clinical and Experimental|April 21, 2009
Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjectsKathleen V Fitch, Lauren M Guggina, Hester M Keough, et al.Antiviral Therapy|September 21, 2017
Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIVSuman Srinivasa, Michael T Lu, Kathleen V Fitch, et al.The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.Journal of the American Heart Association|March 27, 2024
Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE TrialRoger S Zou, Yunfeng Ruan, Buu Truong, et al.Pageof 12